pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
Oximo
Genital Herpes
Oxymo Technologies Inc
0
catalysts
Preclinical
Oxy-133
Osteoporosis
Max Biopharma Inc
0
catalysts
Preclinical
Oxy-210
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Max Biopharma Inc
0
catalysts
Phase 1
P-01
Pancreatic Cancer
← prev
page 119 of 231
next →
131
Pain
89
Neurology
1
Hangzhou Neoantigen Therapeutics Co Ltd
0
catalysts
Preclinical
P-1155
Chronic Obstructive Pulmonary Disease (COPD)
Parion Sciences Inc
0
catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0
catalysts
Phase 2
P-4M01
Periodontal Disease
P4 Microbiome Inc
0
catalysts
Preclinical
P-8
Alzheimer's Disease
Cenna Biosciences Inc
0
catalysts
Preclinical
P-BCMACD19-ALLO1
Autoimmune Disorders
Poseida Therapeutics Inc
0
catalysts
Preclinical
P-MAPA
Schistosomiasis
Farmabrasilis
0
catalysts
Preclinical
P5P Analogues
Unspecified
$MCUJF
MEDICURE INC
0
catalysts
Phase 1
PA-001
Coronavirus Disease 2019 (COVID-19)
PeptiAID Inc
0
catalysts
Phase 2
PALI-2108
Ulcerative Colitis
$PALI
PALISADE BIO, INC.
0
catalysts
PANTOPRAZOLE SODIUM DELAYED-RELEASE
PANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM DELAYED-RELEASE)
MANKIND PHARMA
0
catalysts
PAROXETINE
PAROXETINE (PAROXETINE)
LEGACY PHARMA
0
catalysts
Phase 1
PAS-004
Plexiform Neurofibroma
$KTTA
Pasithea Therapeutics Corp.
0
catalysts
Preclinical
PAX-001
Tendon and Ligament Pain
PAX Therapeutics Inc
0
catalysts
Phase 2
PAX-1
Bile Duct Cancer (Cholangiocarcinoma)
Komipharm International Co Ltd
0
catalysts
Phase 3
PAX-101
suramin hexasodium
African Trypanosomiasis
Fibroblast growth factor 1
Kuvatris Therapeutics Inc
0
catalysts
PAZOPANIB
PAZOPANIB (PAZOPANIB)
EUGIA PHARMA
0
catalysts
Preclinical
PB-207
Rheumatoid Arthritis
Pan-Biome Pharmaceuticals Inc
0
catalysts
phase_0
PBA-0111
Alveolar Soft Part Sarcoma (ASPS)
Pure Biologics SA
0
catalysts
phase_0
PBA-0405
Alveolar Soft Part Sarcoma (ASPS)
Pure Biologics SA
0
catalysts
Preclinical
PBAS-499
Phenylketonuria (PKU)
Pluvia AS
0
catalysts
Phase 1
PBCAR-19B
Diffuse Large B-Cell Lymphoma
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
Phase 2
PBF-999
Prader-Willi Syndrome (PWS)
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Adenosine receptor A2a
Palobiofarma SL
0
catalysts
Phase 2
PBFT-02
Frontotemporal Dementia (Pick Disease)
$PASG
Passage BIO, Inc.
0
catalysts
Phase 2
PBGENE-HBV
Hepatitis B
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
Phase 2
PBGM-01
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
GEMMA Biotherapeutics Inc
0
catalysts
Phase 2
PBI-05204
Metastatic Adenocarcinoma of The Pancreas
Phoenix Biotechnology Inc
0
catalysts